Hypnosis app aims to tame hot flashes for breast cancer patients
NCT ID NCT06552091
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a guided digital self-hypnosis program can reduce hot flashes in women with breast cancer who are on hormone therapy. Hot flashes are a common side effect that often leads patients to stop treatment, raising the risk of cancer returning. Over three weeks, 76 participants will practice daily self-hypnosis sessions, and researchers will track changes in hot flash frequency and severity, as well as quality of life and sleep.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
guided digital self-hypnosis sessions
What this could lead to
If it works, this could offer a drug-free way to manage hot flashes, helping patients stick with their hormone therapy and improve their quality of life.
What could go wrong
This is a small, early-phase trial with only 76 participants, so results may not apply to everyone. Self-hypnosis may not work for all, and the effect might be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut de Cancerologie de Lorraine
RECRUITINGVandœuvre-lès-Nancy, 54500, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••